Journal Article

Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015–2022

Langley, Joanne M., Kibsey, Pamela, Leamon, Jenna, Choi, Kelly B., Srigley, Jocelyn A., Evans, Gerald A., Silva, Anada, Minion, Jessica, Titoria, Reena, Longtin, Yves, Hizon, Romeo, Golding, George R., Lee, Bonita E., Comeau, Jeannette L., Davis, Ian, Science, Michelle, Suh, Kathryn N., Wong, Alice, Engbretson, Meghan, Frenette, Charles, Johnstone, Jennie, Versluys, Kristen, Thampi, Nisha, Oates, Ericka, Lybeck, Cassandra, Anderson, Nicole, Leal, Jenine, Lee, Diane, Katz, Kevin C., Ahmed, Sean, Bakai-Anderson, Suzanne, Du, Tim, Garrod, Matthew, Mertz, Dominik, Chow, Blanda, Hota, Susy S.

2025

Overview

We investigated epidemiologic and molecular characteristics of healthcare-associated (HA) and community-associated (CA) Clostridioides difficile infection (CDI) among adult and pediatric patients in Canadian Nosocomial Infection Surveillance Program hospitals during 2015-2022. Of 30,824 reported CDI cases, 94.9% (29,250/30,824) were among adult (73.2% HA; 26.8% CA) and 5.1% (1,574/30,824) pediatric (77.6% HA; 22.4% CA) patients. During the study period, adult HA CDI rates decreased by 19.9% and CA CDI rates remained stable; pediatric HA CDI rates decreased by 29.6% and CA CDI decreased by 58.3%. Ribotype (RT) 106 was most common among both groups and replaced RT027 as the predominant strain type. RT027 was most associated with adult patients, HA acquisition, severe CDI, and severe outcomes. Moxifloxacin resistance was higher in adult than pediatric cases; clindamycin and rifampin resistance rates were similar between groups. Continued national surveillance is integral to understanding the epidemiology of adult and pediatric CDI in Canada and informing prevention efforts.

• Publisher: U.S. National Center for Infectious Diseases,Centers for Disease Control and Prevention
• Subject: Adolescent / Adult / adult CDI / Adults / Age groups / Aged / Anti-Bacterial Agents - pharmacology / Anti-Bacterial Agents - therapeutic use / Antimicrobial agents / antimicrobial resistance / bacteria / Canada - epidemiology / Care and treatment / Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated / Child / Child, Preschool / Clostridioides difficile / Clostridioides difficile - classification / Clostridioides difficile - drug effects / Clostridioides difficile - genetics / Clostridioides difficile infection / Clostridium infections / Clostridium Infections - epidemiology / Clostridium Infections - history / Clostridium Infections - microbiology / Community-Acquired Infections - epidemiology / Community-Acquired Infections - history / Community-Acquired Infections - microbiology / Cross infection / Cross Infection - epidemiology / Cross Infection - history / Cross Infection - microbiology / Diagnosis / Drug resistance / Drug resistance in microorganisms / Drug Resistance, Bacterial / enteric infections / Epidemiology / Female / Genetic aspects / Genetic variation / Health aspects / Health care / History, 21st Century / Hospitals / Humans / Infant / Infections, Canada, 2015–2022 / Laboratories / Male / Middle Aged / Nosocomial infection / Nosocomial infections / Patients / Pediatrics / Public health / Toxins / Young Adult